ESC 365 - Chronic kidney disease and third generation antiplatelet therapy among real-word acute coronary syndrome patients: Impact on the prognosis at 1-year of the ACHILLES Registry

ESC Premium Access

Chronic kidney disease and third generation antiplatelet therapy among real-word acute coronary syndrome patients: Impact on the prognosis at 1-year of the ACHILLES Registry

Session: Poster Session 5 - Pharmacologic treatment of acute coronary syndromes

Topic: Pharmacotherapy

Speaker: Doctor A. Tello Montoliu (El Palmar, ES)

Event: ESC Congress 2018

Congress Presentation

Add to my library

About the speaker

Doctor Antonio Tello Montoliu

Virgen of the Arrixaca University Clinical Hospital, El Palmar (Spain)

0 follower

6 more presentations in this session

Comparison of clopidogrel with ticagrelor in patients with acute coronary syndrome undergoing percutaneous coronary intervention: interim analysis of COSTIC study

Speaker: Doctor Y. Sun (Wuhan, CN)

Laboratory monitoring of efficacy and safety of atorvastatin high doses in myocardial infarction with ST-segment elevation

Speaker: Associate Professor L. Salyamova (Penza, RU)

Loading dual antiplatelet therapy in Chinese STEMI patients: results from China STEMI Care Project phase 1 (CSCAP-1)

Speaker: Doctor Y. Zhang (Beijing, CN)

Efficiency of quercetin in complex treatment of acute myocardial infarction with ST segment elevation

Speaker: Doctor M. Mirmaksudov (Tashkent, UZ)

Nephroprotective effect of lipid-lowering therapy in patients after STEMI

Speaker: Professor V. Oleinikov (Penza, RU)

Access the full session

Poster Session 5 - Pharmacologic treatment of acute coronary syndromes

Speakers: Doctor A. Tello Montoliu, Doctor Y. Sun, Associate Professor L. Salyamova, Doctor Y. Zhang, Doctor M. Mirmaksudov...

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources